Page last updated: 2024-11-05

rhodamine b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Rhodamine B is a fluorescent dye commonly used in biological and chemical research. It is synthesized through a multi-step process involving the condensation of phthalic anhydride with diethylamino-m-cresol. Rhodamine B exhibits strong fluorescence in the visible spectrum, making it suitable for various applications, including microscopy, flow cytometry, and laser scanning confocal microscopy. Its high quantum yield and excellent photostability contribute to its widespread use. In biological studies, Rhodamine B is employed as a marker for cell tracking, protein labeling, and DNA staining. Its fluorescence properties allow for the visualization and quantification of biological processes. However, Rhodamine B can have cytotoxic effects at high concentrations. This has led to investigations into its potential applications in photodynamic therapy, where it can be used to generate reactive oxygen species upon exposure to light, leading to the destruction of cancer cells. Rhodamine B is also utilized in various industrial applications, including optical sensors, textiles, and dye lasers. The unique properties of Rhodamine B, including its fluorescence, photostability, and potential for both biological and industrial applications, make it an important compound for scientific research and technological advancements.'

rhodamine B: RN & N1 from 9th CI Form Index; RN given refers to parent cpd; structure in Merck Index, 9th ed, #7973; TETRAETHYLRHODAMINE was see RHODAMINES 1975-93; use RHODAMINES to search TETRAETHYLRHODAMINE 1975-93 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

rhodamine B : An organic chloride salt having N-[9-(2-carboxyphenyl)-6-(diethylamino)-3H-xanthen-3-ylidene]-N-ethylethanaminium as the counterion. An amphoteric dye commonly used as a fluorochrome. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6694
CHEMBL ID428971
CHEBI ID52334
SCHEMBL ID16280
MeSH IDM0094768

Synonyms (175)

Synonym
ethanaminium, n-(9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene)-n-ethyl-,chloride
rhodamine s [russian]
fd&c red no. 19
ci basic violet 10
ethanaminium, n-(9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene)-n-ethyl-, chloride
ccris 3985
nsc 10475
(9-(o-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene) diethylammonium chloride
basonyl red 545
ethanaminium, n-(9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene)-n-e- thyl-, chloride
9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium chloride
violet zasadita 10 [czech]
basonyl red 540
ci food red 15
n-(9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene)-n-e- thylethanaminium chloride
hsdb 5244
ci 45170
ammonium, (9-(o-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene)diethyl-, chloride
d&c red no.19
xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, chloride
basonyl red 545fl
rhodamine b500
einecs 201-383-9
d & c red no.19
d&c red no. 19
ethanaminium, n-[9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene]-n-ethyl-, chloride
certiqual rhodamine
d&c red 19
c.i. basic violet 10
nsc-41837
fd and c red no. 19
geranium lake n
calcozine rhodamine bx
rhodamine b extra s
rhodamine s
rhodamine ba
cerise toner x1127
wln: t c666 bo eyj euk2&2 ir bvq& mn2&2 &q &g
rhodamine ba export
mitsui rhodamine bx
diethyl-m-aminophenolphthalein hydrochloride
red no. 213
rhodamine, blue shade
c.i. no. 45170
edicol supra rose b
tetraethylrhodamine
edicol supra rose bs
d and c red no. 19
acid brilliant pink b
rhodamine b500 hydrochloride
rhodamine bxp
cogilor red 321.10
rhodamine fb
hexacol rhodamine b extra
[9-(o-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene] diethylammonium chloride
rhodamine b extra m 310
nsc-10475
akiriku rhodamine b
nsc10475
rhodamine bf
diabasic rhodamine b
rhodamine bxl
rhodamine b extra
iragen red l-u
rhodamine, tetraethyl-
rhodamine o
symulex magenta f
rhodamine bs
brilliant pink b
takaoka rhodamine b
symulex rhodamine b toner f
aizen rhodamine bhc
aizen rhodamine bh
rhodamine b 20-7470
sicilian cerise toner a-7127
tetraethyldiamino-o-carboxyphenyl xanthenyl chloride
elcozine rhodamine b
rheonine b
symulex pink f
adc rhodamine b
c.i. 45170
rhodamine b 500
calcozine rhodamine bl
cosmetic brilliant pink bluish d conc
rhodamine bn
c.i. food red 15
rhodamine bl
rhodamine b chloride
rhodamine bx
9-o-carboxyphenyl-6-diethylamino-3-ethylimino-3-isoxanthene, 3-ethochloride
edicol suppa rose bs
ikada rhodamine b
d & c red no. 19
c.i. 749
rhodamine fb cl
food red 15
basazol red 71p
rhodamine b
rhodamine
nsc41837
calcozine rhodamine bxp
basic rose red
rhodamine lake red b
calcozine red bx
cerise toner x 1127
eriosin rhodamine b
basic violet 10
11411 red
81-88-9
violet zasadita 10
n-[9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene]-n-ethylethanaminium chloride
CHEBI:52334 ,
CHEMBL428971
AKOS000283060
R0040
C19517
dtxsid6042369 ,
dtxcid4022369
tox21_301450
NCGC00255803-01
cas-81-88-9
R0014
9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthenium chloride
ethanaminium, n-(9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene)-n-ethyl-
k7g5scf8il ,
unii-k7g5scf8il
xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, chloride (1:1)
FT-0622587
d&c red no. 19 (delisted)
rhodamine b [hsdb]
rhodamine b [iarc]
aka213
fd&c red no. 19 (delisted) [ii]
fd&c red no. 19 (delisted)
aka-213
d&c red no. 19 (delisted) [ii]
aka213 [inci]
n-(9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene)-n-ethylethanaminium chloride
rhodamine b [mi]
basic violet 10 [inci]
rose b w 3005
SCHEMBL16280
CS-7637
rhodamineb
mfcd00011931
rhodamine b (c.i. 45170)
9-(2-carboxyphenyl)-3,6-bis(diethylamino) xanthylium chloride
HY-Y0016
Q429022
PYWVYCXTNDRMGF-UHFFFAOYSA-N
AS-17153
basic violet 10;brilliant pink b;rhodamine o;tetraethylrhodamine
[9-(2-carboxyphenyl)-6-(diethylamino)xanthen-3-ylidene]-diethylazanium;chloride
SY010955
AMY3544
CCG-269534
D88566
14728-79-1
xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, chloride (1:1), dimer
rhodamine?b
9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthyliumchloride
n-(9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene)-n-e-thylethanaminium chloride
tetraethyldiamino-o-carboxy-phenyl-xanthenyl chloride
d&c red no. 19 (delisted) (ii)
fd&c red no. 19 (delisted) (ii)
fd and c red no 19
d+c red no 19
ci 749
red no 213
cl 45170
diethyl-m-amino-phenolphthalein hydrochloride
ethanaminium, n-(9-(2-carboxyphenyl)-6-(diethylamino)-3h-xanthen-3-ylidene)-n-e-thyl-, chloride
rhodamine b (iarc)
d and c red no 19
rodamina b

Research Excerpts

Overview

Rhodamine B (RhB) is a banned food additive and has been classified as illegal colourant. Rhodamine B is a dye known to have a high affinity for the epidermal layer and to possess fluorescent properties. 6-Rhodamines B amine functions as a highly sensitive fluorescence derivatization reagent.

ExcerptReferenceRelevance
"Rhodamine B (RhB) is a well known dye extensively used in thermometric studies, either considering the decrease in the fluorescence intensity or the lifetime (τ) with temperature. "( Fluorescence lifetime of Rhodamine B in aqueous solutions of polysaccharides and proteins as a function of viscosity and temperature.
Chen, XD; Mercadé-Prieto, R; Rodriguez-Rivera, L, 2017
)
2.2
"Rhodamine B (RhB) is a banned food additive and has been classified as illegal colourant. "( Rhodamine B in spices determined by a sensitive UPLC-MS/MS method.
Hu, J; Li, T; Li, Y; Nie, X; Qiao, H; Tian, L; Wang, M; Yin, D, 2019
)
3.4
"Rhodamine B is a dye known to have a high affinity for the epidermal layer and to possess fluorescent properties. "( 3D imaging of human epidermis micromorphology by combining fluorescent dye, optical clearing and confocal microscopy.
Fernandez, E; Marull-Tufeu, S, 2019
)
1.96
"Rhodamine B is an illegal and potentially carcinogenic food dye. "( A validated LC-MS/MS determination method for the illegal food additive rhodamine B: Applications of a pharmacokinetic study in rats.
Cheng, YY; Tsai, TH, 2016
)
2.11
"6-Rhodamine B amine functions as a highly sensitive fluorescence derivatization reagent for mono- and oligosaccharides; it reacts with the reducing end of saccharides under acidic conditions. "( Rhodamine B amine as a highly sensitive fluorescence derivatization reagent for saccharides in reversed-phase liquid chromatography.
Hayama, T; Ijiri, S; Kazuta, A; Nohta, H; Todoroki, K; Yamaguchi, M; Yoshida, H, 2004
)
2.49
"Rhodamine B is a lipid-soluble, nontoxic dye that fluoresces at longer wavelengths than fluorescein and consequently is detectable at lower concentrations in the ocular tissues. "( Rhodamine B as a test molecule in intraocular dynamics.
Guss, R; Johnson, F; Maurice, D, 1984
)
3.15
"Rhodamine B (Rh B) is a dye which is used in cosmetics such as lipsticks. "( Rhodamine B inhibition of glycosaminoglycan production by cultured human lip fibroblasts.
Kaji, T; Kawashima, T; Sakamoto, M, 1991
)
3.17
"Rhodamine B is a red colored dye that is used in cosmetic products. "( Acute exposure to rhodamine B.
Dire, DJ; Wilkinson, JA, 1987
)
2.05

Effects

Rhodamine B selenolactone is a new fluorescent probe for imaging both Hg(2+) and Ag(+) in live cells to better understand their distinct toxicities to organisms. Rhodamine B has been used as model compound and all experiments were carried out at normal atmospheric pressure and temperature.

ExcerptReferenceRelevance
"Rhodamine B has previously been demonstrated to be useful for marking adult Aedes aegypti males when added to the sugar meal."( Fluorescent markers rhodamine B and uranine for Anopheles gambiae adults and matings.
Aviles, EI; Benedict, MQ; Collins, CM; Dotson, EM; Rotenberry, RD, 2020
)
1.6
"Rhodamine B has the advantage that it appears to be permanent and is less easily confused with auto-fluorescence."( Fluorescent markers rhodamine B and uranine for Anopheles gambiae adults and matings.
Aviles, EI; Benedict, MQ; Collins, CM; Dotson, EM; Rotenberry, RD, 2020
)
1.6
"Rhodamine B (RhB) has been choosen as model molecule to study the loading of nanodiamonds with active moieties and the conditions for their controlled release."( Rhodamine/Nanodiamond as a System Model for Drug Carrier.
Cairone, C; Cianchetta, I; Lenti, S; Orlanducci, S; Reina, G; Rossi, M; Tamburri, E; Terranova, ML, 2015
)
1.14
"Rhodamine B has been used as model compound and all experiments were carried out at normal atmospheric pressure and temperature (25+/-1 degrees C) under open-wide system."( Efficient degradation of Rhodamine B by using ethylenediamine-CuCl2 complex under alkaline conditions.
Duan, P; Li, Y; Liu, W; Wu, M; Yi, Z; Zhang, J, 2009
)
1.38
"Rhodamine B selenolactone has been designed, synthesized, and characterized as a new fluorescent probe for imaging both Hg(2+) and Ag(+) in live cells to better understand their distinct toxicities to organisms. "( Imaging different interactions of mercury and silver with live cells by a designed fluorescence probe rhodamine B selenolactone.
Li, X; Ma, H; Shi, W; Sun, S, 2010
)
2.02

Treatment

Rhodamine B treatment improved MPS IIIA performance towards normal with treated mice having decreased escape latency, decreased incorrect entries and increased correct entries when compared to untreated littermates. hamsters were visibly marked for up to 8 wk, and their feces were fluorescent when examined under a fluorescence microscope.

ExcerptReferenceRelevance
"Rhodamine B-treated hamsters were visibly marked for up to 8 wk, and their feces were fluorescent when examined under a fluorescence microscope."( Evaluation of rhodamine B as an orally delivered biomarker for rodents and a feed-through transtadial biomarker for phlebotomine sand flies (Diptera: Psychodidae).
Foil, LD; Mascari, TM, 2009
)
1.43
"Rhodamine B treatment improved MPS IIIA performance towards normal with treated mice having decreased escape latency, decreased incorrect entries and increased correct entries when compared to MPS IIIA untreated littermates."( Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA.
Byers, S; Fletcher, JM; Klebe, S; Rees, MH; Roberts, AL,
)
1.09

Toxicity

ExcerptReferenceRelevance
"A simple and highly safe poly(3-hydroxybutyrate-co-R-3-hydroxyhexanoate) nanoparticulate delivery system that targets different cell types is developed."( Poly(3-hydroxybutyrate-co-R-3-hydroxyhexanoate) nanoparticles with polyethylenimine coat as simple, safe, and versatile vehicles for cell targeting: population characteristics, cell uptake, and intracellular trafficking.
Chen, GQ; Hall, A; Moghimi, SM; Parhamifar, L; Wang, D; Wu, LP, 2014
)
0.4
"Animal venoms contain a diverse array of proteins and enzymes that are toxic toward various physiological systems."( Rhodamine B-conjugated encrypted vipericidin nonapeptide is a potent toxin to zebrafish and associated with in vitro cytotoxicity.
Ai, N; Chan, JY; Chong, CM; Falcão, CB; Lee, SM; Rádis-Baptista, G; Rêgo, JV; Wang, L, 2015
)
1.86
" Contrastively, unconjugated EVP50 peptide did not display neither toxic nor cytotoxic activities in our in vivo and in vitro models."( Rhodamine B-conjugated encrypted vipericidin nonapeptide is a potent toxin to zebrafish and associated with in vitro cytotoxicity.
Ai, N; Chan, JY; Chong, CM; Falcão, CB; Lee, SM; Rádis-Baptista, G; Rêgo, JV; Wang, L, 2015
)
1.86
" The lethal toxic concentration of RhoB-crotamine was as low as 4 μM, which effectively kill zebrafish larvae in less than 10 min."( Evaluation in zebrafish model of the toxicity of rhodamine B-conjugated crotamine, a peptide potentially useful for diagnostics and therapeutics.
Chan, JY; Chan, SW; Kwan, YW; Lee, SM; Radis-Baptista, G; Zhou, H, 2017
)
0.71
"Bisphenol analogues have been developed as alternatives to bisphenol A (BPA), a common chemical with potential adverse effects on human health."( Evaluation of single and combined toxicity of bisphenol A and its analogues using a highly-sensitive micro-biosensor.
Li, B; Wang, C; Wu, G; Xing, Y; Yuan, X; Zhu, X, 2020
)
0.56

Pharmacokinetics

ExcerptReferenceRelevance
" The aim of this study was to develop a convenient, rapid, and sensitive UHPLC-MS/MS method for pharmacokinetic studies in rats."( A validated LC-MS/MS determination method for the illegal food additive rhodamine B: Applications of a pharmacokinetic study in rats.
Cheng, YY; Tsai, TH, 2016
)
0.67
" Few pharmacokinetic and toxicological investigations have been performed since the first pharmacokinetic study on rhodamine B in 1961."( Pharmacokinetics and Biodistribution of the Illegal Food Colorant Rhodamine B in Rats.
Cheng, YY; Tsai, TH, 2017
)
0.9
"We found that NC-PGA and NC-PEG had similar pharmacokinetic and biodistribution profiles and both were eliminated by hepatobiliary and renal clearance."( In vivo Studies on Pharmacokinetics, Toxicity and Immunogenicity of Polyelectrolyte Nanocapsules Functionalized with Two Different Polymers: Poly-L-Glutamic Acid or PEG.
Bereta, J; Bzowska, M; Cierniak, A; Dyduch, G; Karabasz, A; Mezyk-Kopec, R; Szczęch, M; Szczepanowicz, K, 2019
)
0.51

Compound-Compound Interactions

ExcerptReferenceRelevance
"The degradation of rhodamine B in aqueous solution by using swirling jet-induced cavitation combined with H(2)O(2) was investigated."( Degradation of rhodamine B in aqueous solution by using swirling jet-induced cavitation combined with H2O2.
Guo, P; Guo, W; Wang, C; Wang, J; Wang, X, 2009
)
1.03
" We hereby present a novel technique where high spatial resolution MRI is combined with autofluorescence and reflectance spectroscopy in a bimodal endoluminal probe to extract morphological data and biochemical information, respectively."( Optical spectroscopy combined with high-resolution magnetic resonance imaging for digestive wall assessment: endoluminal bimodal probe conception and characterization in vitro, on organic sample and in vivo on a rabbit.
Beuf, O; Lafarge, L; Ramgolam, A; Sablong, R; Saint-Jalmes, H, 2011
)
0.37

Bioavailability

ExcerptReferenceRelevance
" Estimates of specific absorption rate (SAR) from absorbed power measurements were greater than those estimated from rate of temperature rise, measured at 1 min intervals, probably because this interval is too long to permit accurate estimation of initial temperature rise following start of RF exposure."( Application of a temperature-dependent fluorescent dye (Rhodamine B) to the measurement of radiofrequency radiation-induced temperature changes in biological samples.
Chen, YY; Wood, AW, 2009
)
0.6
"In the recent years a significant development of investigations with regard to bioavailability of ocular drugs has been noticed."( Bovine corneal epithelial primary cultures as an in vitro model for ophthalmic drugs studies.
Paluch, M; Sieradzki, E; Sitkiewicz, D; Stawarski, T; Sygitowicz, G; Zapolska-Downar, D,
)
0.13
" However, in vivo, the efficiency of CPP delivery to the cytosol remains unsatisfactory owing to endosomal entrapment and/or systemic toxicity, which severely restrict their bioavailability and efficacy in in vivo applications."( Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
Fan, F; Gong, C; Luo, M; Ma, Y; Yang, F; Zhang, YH, 2012
)
0.38
" Estimates of rate of initial temperature rise (using both probe measurement and the dye method) accord well with estimates of local specific energy absorption rate (SAR)."( A measurement and modeling study of temperature in living and fixed tissue during and after radiofrequency exposure.
Bermingham, JF; Chen, YY; McIntosh, RL; Wood, AW, 2014
)
0.4
" Epidermal growth factor receptor (EGFR) is overexpressed in many ovarian cancers, therefore we modified EGF on the liposomes (CS-EGF-Lip) to specifically target EGFR-expressing tumors, thereby increasing the bioavailability and efficacy of CDDP."( Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Chen, L; Di, W; Liu, T; Qiu, L; Wang, X; Wang, Y; Zhou, J, 2014
)
0.4
" As we expected, these tri-component polynorbornenes exhibit significant enhancement in anti-thrombotic efficacy and bioavailability in vivo."( A modular designed copolymer with anti-thrombotic activity and imaging capability.
Chen, B; Feng, K; Peng, S; Tung, CH; Wu, LZ; Xie, N; Zhang, LP; Zhao, M, 2014
)
0.4
" In spite of lower imprinting factor, the relative bioavailability of the gastro-floating LC-MIP was 180."( Solvent-responsive floating liquid crystalline-molecularly imprinted polymers for gastroretentive controlled drug release system.
Chen, M; Huang, YP; Liu, ZS; Pang, QQ; Tang, L; Wang, XL; Zhang, LP, 2017
)
0.46
" It is usually treated with eye drops, which has low bioavailability owing to rapid clearance from the ocular surface and leads to poor patient compliance and side effects."( Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
Li, J; Liu, D; Pan, W; Song, Y; Tan, G; Yu, Y, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
"A sensitive spectrophotometric assay has been developed for the determination of methoxamine in pure dosage form and in its pharmaceutical preparations."( Spectrophotometric determination of methoxamine using cerium(IV) in presence of sodium lauryl sulphate and rhodamine-B.
al-Obaid, AM; Alwarthan, AA, 1997
)
0.3
" Through numerous experiments, the influences of five parameters including light source, pH, reaction time, dosage of Fenton reagent, and initial dye concentration were investigated intensively."( [Photo-fenton oxidation processes used in the degradation of rhodamine B].
Xiang, XY; Zheng, HL, 2004
)
0.56
" For higher dosage of Cerium, the absorbance edge shifts to blue slightly."( [Preparation and photocatalytic activity of boron doped CeO2/TiO2 mixed oxides].
Liang, JR; Tang, XH; Wang, BG; Wei, CH, 2006
)
0.33
" From the results of the PLIF imaging studies with rhodamine-B, fluorescein, and enteric-coated tablets, it was seen that "hot spots" affecting the dissolution performance of enteric dosage forms are not generated during the neutralization step of the method A enteric test namely when the media is added rapidly or outside of the recirculating region that surrounds the paddle shaft."( Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
Clemens, NT; Gamba, M; Miller, DA; Purvis, TP; Sauer, D; Williams, RO, 2007
)
0.34
" The effect of parameters such as pH, adsorbent dosage and initial dye concentration was studied."( Removal of rhodamine B from aqueous solution by adsorption onto sodium montmorillonite.
Basakaralingam, P; Preethi, S; Selvam, PP; Sivanesan, S; Sivasamy, A; Thinakaran, N, 2008
)
0.74
" The variation of oxidation efficiency against H(2)O(2) dosage and amount of exposed surface area per unit volume was evaluated and correlated with the adsorption behavior in the absence of oxidant."( Fenton-like oxidation of Rhodamine B in the presence of two types of iron (II, III) oxide.
Deng, N; Hanna, K; Xue, X, 2009
)
0.66
" These systems provide an opportunity for the development of controlled release dosage forms with greater effectiveness in the treatment of chronic conditions."( Fabrication and physical-chemical characterisation of polyelectrolyte microparticles: platform for controlled release of bioactives.
Alany, RG; Sun, Y; Travas-Sejdic, J; Wen, J, 2009
)
0.35
"One titrimetric and two spectrophotometric methods which are simple, sensitive and rapid are described for the assay of salbutamol sulphate (SBS) in bulk drug and in tablet dosage forms using N-bromosuccinimide (NBS) and two dyes, rhodamine-B and methylene blue, as reagents."( Rapid titrimetric and spectrophotometric methods for salbutamol sulphate in pharmaceuticals using N-bromosuccinimide.
Basavaiah, K; Ramakrishna, V; Somashekar, BC, 2007
)
0.34
" The dosage formulation SAB@MSNs-RhB effectively protected the loaded drug SAB from decomposition."( An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
Chen, F; Guo, L; He, Q; Shi, J; Zhang, J; Zhu, Z, 2010
)
0.36
"5% of bait mass dosed to deliver >10 mg RB per kg target animal mass."( Use of rhodamine B as a biomarker for oral plague vaccination of prairie dogs.
Fernandez, JR; Rocke, TE, 2011
)
0.82
" The influence of various degradation parameters such as solar illumination time, initial dye concentration, dosage and pH was investigated."( Functionalization of tungsten oxide into MWCNT and its application for sunlight-induced degradation of rhodamine B.
Gupta, VK; Saleh, TA, 2011
)
0.58
" These studies showed that enhanced drug release and tunable drug dosage can be achieved by using ultrasound irradiation."( Nanoporous polymeric nanofibers based on selectively etched PS-b-PDMS block copolymers.
Buyukserin, F; Demirel, G; Demirel, GB; Morris, MA, 2012
)
0.38
" The dosage of drug (rhodamine B) released in these cycles could be controlled to deliver approximately equal doses by altering the release time in the swollen state."( A mathematical model for pulsatile release: controlled release of rhodamine B from UV-crosslinked thermoresponsive thin films.
Aldabbagh, F; Carroll, WM; Gorelov, AV; Meere, MG; Rochev, Y; Vo T N, T; Yang, R, 2012
)
0.93
"Transdermal drug delivery systems (TDDSs) represent more reliable and consistent methods of drug dosing than oral administration."( Transdermal drug delivery using disk microneedle rollers in a hairless rat model.
An, JH; Kim, BJ; Kim, HM; Kim, MN; Lim, YY, 2012
)
0.38
" The effect of pH, catalyst dosage and dissolved iron on the degradation efficiency were studied."( [Degradation of organic pollutants by photo-Fenton-like system with hematite].
Gu, Y; He, Y; Huang, YP; Li, RP; Yang, H; Zhang, AQ; Zhang, Y, 2012
)
0.38
"In aerobiology, dose-response studies are used to estimate the risk of infection to a susceptible host presented by exposure to a specific dose of an airborne pathogen."( A method to quantify infectious airborne pathogens at concentrations below the threshold of quantification by culture.
Cutler, TD; Hoff, SJ; Wang, C; Zimmerman, JJ, 2013
)
0.39
" The effects of various reaction parameters such as H2O2 dosage, temperature, initial pH value, Fe–Si–B dosage and initial RhB concentration on the degradation of RhB were studied."( Efficient degradation of rhodamine B using Fe-based metallic glass catalyst by Fenton-like process.
Pan, Y; Wang, X; Wu, J; Zhu, Z, 2014
)
0.71
" The effects of various experimental factors including ultrasonic frequency (f), reaction solution temperature (T), catalyst dosage (Ccatalyst), initial RhB concentration (CRhB), and pH value on the sonocatalysis efficiency were investigated."( Sonocatalytic degradation of RhB over LuFeO3 particles under ultrasonic irradiation.
Li, RS; Wang, XX; Xian, T; Yang, H; Zhang, HM; Zhou, M, 2015
)
0.42
" The operational parameters such as Fe(2+) dosage and current density were optimized, and comparison among different modified methods-polytetrafluoroethylene-carbon black (PTFE-CB), polytetrafluoroethylene-carbon nanotube (PTFE-CNT), electrodeposition-CB, and electrodeposition-CNT-showed 98."( Efficient degradation of rhodamine B using modified graphite felt gas diffusion electrode by electro-Fenton process.
Mu, T; Olajuyin, AM; Tian, J; Xing, J; Yang, M, 2016
)
0.74
" Unfortunately, current implantable drug delivery systems provide limited options for intervention in the case of an adverse reaction to the drug or the need for dosage adjustment."( Remote magnetic switch off microgate for nanofluidic drug delivery implants.
Ballerini, A; Demarchi, D; Farina, M; Grattoni, A; Rizzo, G; Thekkedath, U; Torchio, G, 2017
)
0.46
" Response surface methodology (RSM) coupled with grey relational analysis (GRA) was used to evaluate the effects of voltage, initial pH, aeration rate and NaCl dosage on RhB removal and energy consumption of the 3DER."( Multiple response optimization for high efficiency energy saving treatment of rhodamine B wastewater in a three-dimensional electrochemical reactor.
Ji, J; Li, XY; Liu, Y; Xu, J; Yang, XY, 2018
)
0.71
" However, the clinically used dosage has poor tissue permeability and injection safety."( Transdermal permeability of triamcinolone acetonide lipid nanoparticles.
Ban, J; Chen, D; Chen, F; Qin, Z; Tan, Y; Wang, Y, 2019
)
0.51
" Effect of various biosorption parameters such as pH, initial concentration of RB, biosorbent dosage and contact time were studied."( Biosorption of Rhodamine B onto novel biosorbents from Kappaphycus alvarezii, Gracilaria salicornia and Gracilaria edulis.
Rangabhashiyam, S; Selvakumar, A, 2019
)
0.87
" The experiments were carried out based on a Box-Behnken design (BBD) with the input variables of MWCNTs dosage (0."( Adsorption onto MWCNTs Coupled with Cloud Point Extraction for Dye Removal from Aqueous Solutions: Optimization by Experimental Design.
Osaghi, B; Safa, F, 2021
)
0.62
" This is a critical result, as it indicates the robust consistency of UiO-66, a critical feature for pulmonary drug delivery, which is plagued by inconsistent dosage because of variable properties."( Evaluating UiO-66 Metal-Organic Framework Nanoparticles as Acid-Sensitive Carriers for Pulmonary Drug Delivery Applications.
Attia, L; Bloch, ED; Decker, GE; Fromen, CA; Jarai, BM; Stillman, Z, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
fluorescent probeA role played by a fluorescent molecular entity used to study the microscopic environment by fluorescence spectroscopy.
histological dyeA dye used in microscopic or electron microscopic examination of cells and tissues to give contrast and to highlight particular features of interest, such as nuclei and cytoplasm.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organic chloride salt
xanthene dyeA dye derived by condensation of phthalic anhydride with resorcinol (and derivatives) or m-aminophenol (and derivatives).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency11.24960.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency11.24960.002541.796015,848.9004AID1347398
GLI family zinc finger 3Homo sapiens (human)Potency30.84110.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency52.61140.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743042; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency38.57080.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency58.91460.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency61.13060.000417.946075.1148AID1346784
retinoid X nuclear receptor alphaHomo sapiens (human)Potency18.77370.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency33.59240.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency24.33650.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency44.99450.000229.305416,493.5996AID1259244; AID1259248; AID743078; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency13.80060.001024.504861.6448AID743212
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency24.54120.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency29.19450.023723.228263.5986AID743223; AID743241
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency61.13060.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency35.27740.001628.015177.1139AID1224843; AID1224895; AID1259393
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency34.67130.154917.870243.6557AID1346891
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency23.27060.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency15.96230.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency21.83380.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency50.45740.000627.21521,122.0200AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency48.55770.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency48.55770.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (20)

Assay IDTitleYearJournalArticle
AID1777631Fluorescence property of the compound in DMSO assessed as quantum yield2021ACS medicinal chemistry letters, Aug-12, Volume: 12, Issue:8
A Green-Absorbing, Red-Fluorescent Phenalenone-Based Photosensitizer as a Theranostic Agent for Photodynamic Therapy.
AID679072TP_TRANSPORTER: transepithelial transport of Rhodamine at a concentration of 10 uM in MDR1-expressing MDCK cells2003Pharmaceutical research, Aug, Volume: 20, Issue:8
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
AID1727475Cytotoxicity against human A-375 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum.
AID1727481Cytotoxicity against human A2780 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum.
AID1431434Cytotoxicity against human HT-29 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1727487Cytotoxicity against mouse NIH3T3 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum.
AID1431435Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1431436Cytotoxicity against human A549 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1742012Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in MDCK cells assessed as inhibition of viral replication measured after 36 hrs by CellTiter-Glo assay2020European journal of medicinal chemistry, Nov-01, Volume: 205Rhodamine B-based fluorescent probes for molecular mechanism study of the anti-influenza activity of pentacyclic triterpenes.
AID1727484Cytotoxicity against human FaDu cells assessed as reduction in cell viability measured after 72 hrs by SRB assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum.
AID1727473Cytotoxicity against human HEK293 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum.
AID1431432Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1727477Cytotoxicity against human HT-29 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum.
AID679073TP_TRANSPORTER: transepithelial transport of Rhodamine at a concentration of 10 uM in Caco-2 cells2003Pharmaceutical research, Aug, Volume: 20, Issue:8
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
AID1727479Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by SRB assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Cytotoxic triterpenoid-safirinium conjugates target the endoplasmic reticulum.
AID1742011Antiviral activity against Influenza A virus A/WSN/33(H1N1) infected in MDCK cells assessed as inhibition of viral replication at 100 uM measured after 36 hrs by CellTiter-Glo assay2020European journal of medicinal chemistry, Nov-01, Volume: 205Rhodamine B-based fluorescent probes for molecular mechanism study of the anti-influenza activity of pentacyclic triterpenes.
AID1431433Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1431437Cytotoxicity against human 8505C cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1431438Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2017European journal of medicinal chemistry, Feb-15, Volume: 127Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.
AID1742013Cytotoxicity against dog MDCK cells assessed as reduction in cell viability measured after 36 hrs by Celltiter-Glo luminescence assay2020European journal of medicinal chemistry, Nov-01, Volume: 205Rhodamine B-based fluorescent probes for molecular mechanism study of the anti-influenza activity of pentacyclic triterpenes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,702)

TimeframeStudies, This Drug (%)All Drugs %
pre-199052 (3.06)18.7374
1990's65 (3.82)18.2507
2000's317 (18.63)29.6817
2010's1028 (60.40)24.3611
2020's240 (14.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 69.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index69.86 (24.57)
Research Supply Index7.48 (2.92)
Research Growth Index5.34 (4.65)
Search Engine Demand Index123.24 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (69.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials15 (0.85%)5.53%
Reviews10 (0.57%)6.00%
Case Studies5 (0.28%)4.05%
Observational1 (0.06%)0.25%
Other1,727 (98.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]